Clearance Summary
Optimos Cystotome received FDA 510(k) clearance under submission number K223256, sponsored by Taewoong Medical Co., Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Gastroenterology, Urology review panel. The statutory decision date of record is 2023-04-05.
- Submission: K223256
- Applicant / Sponsor: Taewoong Medical Co., Ltd.
- Clearance pathway: Traditional
- Review panel: Gastroenterology, Urology
- Device class: Class II
- Regulation citation: 21 CFR 876.4300
- Decision date: 2023-04-05
Classification & Regulation
This clearance is catalogued under FDA product code KNS and 21 CFR 876.4300, within the Gastroenterology, Urology review panel as a Class II device.